This model, designating high CHAC1 expression as a risk factor, aligns closely with the aforementioned observation of CHAC1 upregulation in late-stage ccRCC and its association with poor prognosis, collectively highlighting the potential of CHAC1 as a biomarker for advanced/high-risk ccRCC. Here, CHAC1 is linked to nonpapillary renal cell carcinoma.